%0 Journal Article
%T 1例艾滋病合并播散性隐球菌病患者的药学监护<br>A Case of Pharmaceutical Care of AIDS Patients with Disseminated Cryptococcus
%A 彭琰淇
%A 杨莉
%A 马翠莲
%A 高丽
%A 宋贤
%J Medical Diagnosis
%P 239-243
%@ 2164-5418
%D 2025
%I Hans Publishing
%R 10.12677/md.2025.153031
%X 目的&#65306;探讨临床药师在艾滋病合并播散性隐球菌病患者中的药学服务方法。方法&#65306;临床药师参与1例艾滋病合并播散性隐球菌病患者的药物治疗全过程&#65292;对抗真菌治疗、ART启动时机及方案、合并感染的抗菌药物选择及药物不良反应的处理及上报等方面进行了全程的药学监护。结果&#65306;患者顺利完成了抗真菌诱导期的治疗&#65292;病原学结果转阴&#65292;启动了ART&#65292;好转出院。结论&#65306;临床药师应积极参与到临床药物治疗中&#65292;开展药学服务&#65292;保障用药安全。<br>Objective: To explore the pharmaceutical method of clinical paharmacists in patients with AIDS complicated with disseminated cryptococcus. Methods: Clinical paharmacists participated in the whole process of drug therapy for a case of AIDS patients with disseminated cryptococcus, and conducted pharmaceutical care in the whole process of antifungal therapy, the timing and program of ART initiation, the selection of antibacterial drugs for co-infection, the treatment and reporting of adverse drug reactions, etc. Results: The patient successfully completed the antifungal induction phase of treatment, the etiological results turned negative, ART was activated, and the patient was discharged with improvement. Conclusion: Clinical pharmacist should actively participate in clinical drug treatment, carry out pharmaceutical care, and ensure drug safety.
%K 艾滋病&#65292
%K 播散性隐球菌病&#65292
%K 药学监护<br>AIDS
%K Disseminated Cryptoccosis
%K Pharmaceutical Care
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=115688